| Vol. 4.30 – 30 November, 2023 |
| |
|
|
| The authors re-analyzed a dataset which detected Streptococcus agalactiae DNA in the placenta in ~5% of women before the onset of labour as a case control study of neonatal unit admission. [Nature Microbiology] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers observed the pathological changes of the ovaries at different time points during chemotherapy, including the number of follicles, granulosa cell proliferation, oxidative stress damage, ovarian fibrosis, and inflammatory reaction. [Inflammation And Regeneration] |
|
|
|
| Investigators found that administration of human umbilical cord MSC-exosome suppressed traumatic brain injury-induced inflammation and ferroptosis. [Brain Research] |
|
|
|
| The authors compared Angptl7 levels between the autologous cord blood mononuclear cells infusion and control groups. Subsequently, the association between cord blood Angptl7 levels and bronchopulmonary dysplasia incidence in a cohort of very preterm neonates was assessed. [Molecular Medicine Reports] |
|
|
|
| To investigate the effects of HPE on the regulation of allergy with respect to the biological functions of mast cells, the mast cell line C57 or HMC-1 cells were treated with HPE followed by the assessment of cell proliferation, apoptosis, activation, chemotaxis and phagocytosis. [Allergy Asthma And Clinical Immunology] |
|
|
|
| Researchers retrospectively analyzed all ELGANs RBC Tx over the past three years, estimated local cord blood availability, and assesed interest in this project, and implementation barriers, through stakeholder surveys. [Journal Of Perinatology] |
| |
|
|
|
| To evaluate the benefits and harms of stem cell‐based interventions for the treatment of stroke in newborn infants compared to control or stem‐cell based interventions of a different type or source. [Cochrane Database Of Systematic Reviews] |
|
|
|
|
| Just 3% of more than 3,700 studies run exclusively in Canada over a recent 10-year period were registered prospectively, reported results, and published the findings, underscoring ongoing concerns about clinical trial transparency, according to a new analysis. [STAT News] |
|
|
|
|
| February 14 – 18, 2024 Cancun, Mexico |
|
|
|
|
|
| Ottawa Hospital Research Institute – Ottawa, Ontario, Canada |
|
|
|
| University of York – York, England, United Kingdom |
|
|
|
| University of York – York, England, United Kingdom |
|
|
|
| Applied Stem Cell – Milpitas, California, United States |
|
|
|
| University of California, Los Angeles – Los Angeles, California, United States |
|
|
|
|